Skip to main content

Advertisement

Log in

Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To prospectively assess discontinuation of indwelling bladder catheterization (IBC) and relief of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) following prostate artery embolization (PAE) in poor surgical candidates.

Methods

Patients ineligible for surgical intervention were offered PAE after at least 1 month of IBC for management of urinary retention secondary to BPH; exclusion criteria for PAE included eligibility for surgery, active bladder cancer or known prostate cancer. Embolization technical and clinical success were defined as bilateral prostate embolization and removal of IBC, respectively. Patients were followed for at least 6 months and evaluated for International Prostate Symptom Score, quality of life, prostate size and uroflowmetric parameters.

Results

A total of 43 patients were enrolled; bilateral embolization was performed in 33 (76.7%), unilateral embolization was performed in 8 (18.6%), and two patients could not be embolized due to tortuous and atherosclerotic pelvic vasculature (4.7%). Among the patients who were embolized, mean prostate size decreased from 75.6 ± 33.2 to 63.0 ± 23.2 g (sign rank p = 0.0001, mean reduction of 19.6 ± 17.3%), and IBC removal was achieved in 33 patients (80.5%). Clavien II complications were reported in nine patients (21.9%) and included urinary tract infection (three patients, 7.3%) and recurrent acute urinary retention (six patients, 14.6%). Nine patients (22.0%) experienced post-embolization syndrome.

Conclusions

PAE is a safe and feasible for the relief of LUTS and IBC in highly comorbid patients without surgical treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8.

    Article  PubMed  Google Scholar 

  2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.

    Article  PubMed  Google Scholar 

  3. European Association of Urology. Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) (2014). http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf. Accessed 4 Mar 2015.

  4. American Urological Association. Guideline: management of benign prostatic hyperplasia (rev. 2010). https://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf. Accessed 10 May 2015.

  5. Carnevale FC, Antunes AA, da Motta Leal Filho JM, Cerri LMO, Baroni RH, Marcelino ASZ, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Interv Radiol. 2010;. doi:10.1007/s00270-009-9727-z.

    Google Scholar 

  6. Pisco J, Pinheiro LC, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;. doi:10.1148/radiol/12111601.

    PubMed  Google Scholar 

  7. Kurbatov D, Russo GI, Lepetukhin A, Dubsky S, Sitkin I, Morgia G, et al. Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study. Urology. 2014;84:400–4.

    Article  PubMed  Google Scholar 

  8. Antunes AA, Carnevale FC, da Motta Leal Filho JM, Yoshinaga EM, Cerri LMO, Baroni RH, et al. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia: a prospective, single-center pilot study. Cardiovasc Interv Radiol. 2013;. doi:10.1007/s00270-013-0611-5.

    Google Scholar 

  9. de Assis AM, Moreira AM, de Paula Rodrigues VC, Yoshinaga EM, Antunes AA, Harward SH, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates >90 g: a prospective, single-center study. J Vasc Interv Radiol. 2015;26:87–93.

    Article  PubMed  Google Scholar 

  10. Grosso M, Balderi A, Arnò M, Sortino D, Antonietti A, Pedrazzini R, et al. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients. Radiol Med. 2014;. doi:10.1007/s11547-014-0447-3.

    PubMed  Google Scholar 

  11. Bhatia S, Kava B, Pereira K, Kably I, Harward S, Narayanan G. Prostate artery embolization for giant prostatic hyperplasia. J Vasc Interv Radiol. 2015;26:1583–5.

    Article  PubMed  Google Scholar 

  12. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51.

    Article  CAS  PubMed  Google Scholar 

  13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  14. European Association of Urology. Guidelines on reporting and grading of complications after urologic surgical procedures. http://uroweb.org/wp-content/uploads/30-Reporting-complications_LR.pdf. Accessed 1 Dec 2015.

  15. Carnevale FC, Moreira AM, Antunes AA. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2014;. doi:10.1007/s00270-014-0908-z.

    Google Scholar 

  16. Fabian KM. The intra-prostatic “partial catheter” (urological spiral). Urologe A. 1980;19:236–8.

    CAS  PubMed  Google Scholar 

  17. Armitage JN, Cathcart PJ, Rashidian A, de Nigris E, Emberton M, van der Meulen JHP. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol. 2007;177:1619–24.

    Article  CAS  PubMed  Google Scholar 

  18. Silva J, Silva C, Saraiva L, Silva A, Pinto R, Dinis P, et al. Intraprostatic Botulium toxin type A injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement: effect on prostate volume and micturition resumption. Euro Urol. 2008;53:153–9.

    Article  CAS  Google Scholar 

  19. Marberger M, Chartier-Kastler E, Egerdie B, Lee KS, Grosse J, Bugarin D, et al. A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia. Eur Urol. 2013;63:496–503.

    Article  CAS  PubMed  Google Scholar 

  20. Magno C, Mucciardi G, Gali A, Anastasi G, Inferrera A, Morgia G. Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients. Int Urol Nephrol. 2008;40:941–6.

    Article  PubMed  Google Scholar 

  21. Grise P, Plante M, Palmer J, Martinez-Sagarra J, Hernandez C, Schettini M, et al. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol. 2004;46:496–501.

    Article  CAS  PubMed  Google Scholar 

  22. Ikari O, Leitão VA, D’Ancona CAL, Matheus WE, Netto NR. Intravesical calculus secondary to ethanol gel injection into the prostate. Urol. 2005;65:1002.

    Article  PubMed  Google Scholar 

  23. Wang MQ, Wang Y, Yan JY, Yuan K, Zhang GD, Duan F, Li K. Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. World J Urol. 2016;34:1275–1283.

    Article  PubMed  Google Scholar 

  24. Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia: how I do it. Cardiovasc Interv Radiol. 2013;. doi:10.1007/s00270-013-0680-5.

    Google Scholar 

  25. Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21:261–74.

    Article  PubMed  Google Scholar 

  26. Moreira AM, Marques CFS, Antunes AA, Nahas CSR, Nahas SC, de Gregorio Ariza MA, et al. Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature. Cardiovasc Interv Radiol. 2013;. doi:10.1007/s00270-013-0739-3.

    Google Scholar 

  27. Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2011;22:11–9.

    Article  PubMed  Google Scholar 

  28. Bilhim T, Pisco JM, Furtado A, Casal D, Pais D, Pinheiro LC, et al. Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography. Eur Radiol. 2011;21:1119–26.

    Article  PubMed  Google Scholar 

  29. Bagla S, Rholl KS, Sterling KM, van Breda A, Papadouris D, Cooper JM, et al. Utility of cone-beam CT imaging in prostatic artery embolization. J Vasc Interv Radiol. 2013;24:1603–7.

    Article  PubMed  Google Scholar 

  30. Laborda A, de Assis AM, Ioakeim I, Sánchez-Ballestín M, Carnevale FC, de Gregorio MA. Radiodermitis after prostatic artery embolization: case report and review of the literature. Cardiovasc Interv Radiol. 2015;. doi:10.1007/s00270-015-1083-6.

    Google Scholar 

  31. Lin YT, Amouyal G, Thiounn N, Pellerin O, Pereira H, Del Giudice C, et al. Intra-vesical prostatic protrusion (IPP) can be reduced by prostatic artery embolization. Cardiovasc Interv Radiol. 2015;. doi:10.1007/s00270-015-1235-8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabiane Barbosa.

Ethics declarations

Conflict of interest

SHH and FCC are consultants for Merit Medical Systems, Inc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rampoldi, A., Barbosa, F., Secco, S. et al. Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates. Cardiovasc Intervent Radiol 40, 530–536 (2017). https://doi.org/10.1007/s00270-017-1582-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-017-1582-8

Keywords

Navigation